Study reveals mutations that drive therapy-related myeloid neoplasms in children
Study predicts UK COVID-19 vaccination program will very quickly reduce deaths but more slowly bring down ICU admissions
12 February 2021Synthetic ‘mini’ receptors block atherosclerosis
12 February 2021Study reveals mutations that drive therapy-related myeloid neoplasms in children
Children treated for cancer with approaches such as chemotherapy can develop therapy-related myeloid neoplasms (a second type of cancer) with a dismal prognosis. Scientists at St. Jude Children’s Research Hospital have characterized the genomic abnormalities of 84 such myeloid neoplasms, with potential implications for early interventions to stop the disease. A paper detailing the work was published today in Nature Communications.
